Cambridge, Massachusetts-based Third Harmonic Bio joined fellow sector IPOs by Seattle-based Know Labs and Texas-based BioAffinity Technologies.
Health, Wellness & Biotech
CytoReason and Pfizer are re-upping their three-year partnership with a fresh, ambitious goal. The companies announced they would renew their...
The psychedelic drug startup industry isn't blowing up quite the way industry watchers expected. But startups in the space that aren't drug related...
After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding startups in the psychedelics...
Biomedical platform Galvanize Therapeutics announced on Thursday it raised $100 million in Series B financing led by Fidelity Management and Research...
We thought it would be interesting to see if there are unexpected places where startup funding is on the rise. Turns out, there are quite a few.
Paris-based genomics-focused biotech startup SparingVision has raised $75 million in a round led by Jeito Capital and UPMC Enterprises to gear up to...
Amid 2022’s economic uncertainty, startups are being forced to cut back—some in the form of layoffs—to weather the market. Here's what we're seeing.
Redesign Health, the upstart behind a slew of telehealth apps, health care fintech companies, and comprehensive care platforms, announced on Tuesday...
Pharmaceutical company Pfizer has requested to join VitaDAO, a blockchain-based biotech collective that requires cryptocurrency buy-in, as a...
August was slow, but if the first full week of September is a harbinger, things may be picking up. Several U.S.-based startups saw large rounds this...
67.1K Followers